 | Redhill Biopharma Ltd. | |||
| NCM : RDHL || Location: Israel | ||||
$0.42-0.01 (-1.87%) |
0.19 M | 0.4 - 0.44 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.907 M |
| March 15, 2024 | 1.056 M |
| Feb. 29, 2024 | 0.376 M |
| Feb. 15, 2024 | 0.616 M |
| Jan. 31, 2024 | 1.114 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2022 | -0.03 | -0.20 | -566.70% |
| 03/31/2022 | -0.23 | -0.30 | -30.40% |
| 12/31/2021 | -0.33 | -0.50 | -51.50% |
| 09/30/2021 | -0.21 | -0.50 | -138.10% |
| 06/30/2021 | -0.12 | -0.60 | -400.00% |
RDHL Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 31.867M | Shares Float | 31.867M |
| Short Float | 0.907M | Market Cap | 13.70M |
| Institution ownership | 6.25% | Insider ownership | 0.000% |
| Earnings Date | 06/10/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 4.00 | Forward EPS | 0.03 |